Surviving life-threatening MDMA (3,4-methylenedioxymethamphetamine, ecstasy) toxicity caused by ritonavir (RTV)

被引：9
|
作者：
Papaseit, Esther [1 ,4 ]
Vazquez, Antonia [2 ]
Perez-Mana, Clara [1 ,4 ]
Pujadas, Mitona [1 ]
de la Torre, Rafael [1 ,3 ]
Farre, Magi [1 ,4 ]
Nolla, Joan [2 ,3 ]
机构：
[1] IMIM Hosp del Mar Res Inst, Human Pharmacol & Clin Neurosci Res Grp, Neurosci Res Program, Barcelona, Spain
[2] Hosp del Mar, Intens Care Unit, Barcelona, Spain
[3] Dept Expt & Hlth Sci CEXS UPF, Barcelona, Spain
[4] UAB, Dept Pharmacol Therapeut & Toxicol, Barcelona, Spain
来源：
INTENSIVE CARE MEDICINE | 2012年 / 38卷 / 07期
关键词：
HUMANS;
D O I：
10.1007/s00134-012-2537-9
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
下载
收藏
页码：1239 / 1240
页数：2
相关论文
共 50 条
  • [41] MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: The neuropsychobiological implications of taking it at dances and raves
    Parrott, AC
    NEUROPSYCHOBIOLOGY, 2004, 50 (04) : 329 - 335
  • [42] The hyperthermia mediated by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) is sensitive to sex differences
    Wyeth, Richard P.
    Mills, Edward M.
    Ullman, Alison
    Kenaston, M. Alexander
    Burwell, Johanna
    Sprague, Jon E.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2009, 235 (01) : 33 - 38
  • [43] EFFECTS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE ( MDMA, 'ECSTASY') ON ARGININE VASOPRESSIN IN HEALTHY VOLUNTEERS
    Baggott, M. J.
    Garrison, K.
    Galloway, G. P.
    Mendelson, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S37 - S37
  • [44] Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in rat
    Upreti, Vijay V.
    Eddington, Natalie D.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (04) : 1593 - 1605
  • [45] Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users
    Una D. McCann
    Robert R. Edwards
    Michael T. Smith
    Kristen Kelley
    Michael Wilson
    Francis Sgambati
    George Ricaurte
    Psychopharmacology, 2011, 217 : 475 - 484
  • [46] Antidotal effect of olanzapine in serotonin toxicity caused by a suicidal 3,4-methylenedioxymethamphetamine (MDMA) overdose
    Lindeman, Erik
    Ottosson, Linn
    Helander, Anders
    CLINICAL TOXICOLOGY, 2023, 61 : 67 - 67
  • [47] Morphological adaptations in the brain motive circuit induced by 3,4-methylenedioxymethamphetamine (MDMA; ecstasy)
    Ball, Kevin
    FASEB JOURNAL, 2010, 24
  • [48] EFFECTS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, 'ECSTASY') ON ARGININE VASOPRESSIN IN HEALTHY VOLUNTEERS.
    Baggott, M. J.
    Garrison, K.
    Galloway, G. P.
    Mendelson, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S3 - S3
  • [49] Changes in gene expression induced by prenatal 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) exposure
    Lyles, J
    Cai, NS
    Cadet, JL
    FASEB JOURNAL, 2003, 17 (05): : A1213 - A1213
  • [50] Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver
    Moon, Kwan-Hoon
    Upreti, Vijay V.
    Yu, Li-Rong
    Lee, Insong J.
    Ye, Xiaoying
    Eddington, Natalie D.
    Veenstra, Timothy D.
    Song, Byoung-Joon
    PROTEOMICS, 2008, 8 (18) : 3906 - 3918
12345